Matsuya Yuji, Yu Zhong, Yamamoto Naoki, Mori Masao, Saito Haruo, Takeuchi Makoto, Ito Mamiko, Nemoto Hideo
Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University, 2630 Sugitani, Toyama 930-0914, Japan.
Bioorg Med Chem. 2005 Jul 15;13(14):4383-8. doi: 10.1016/j.bmc.2005.04.056.
Several new phorbol derivatives having ethereal substituents at the 12-position were synthesized and subjected to biological evaluation to find new candidates of an anti-HIV agent. Among them, 12-O-(methoxymethyl)phorbol 13-decanoate showed potent inhibitory activity against infection of HIV-1 in MT-4 cells (EC50: 1.3 ng/mL) and relatively low cytotoxicity (CC50: 8.3 microg/mL). This compound was also found to have sufficient stability in mouse plasma compared with the corresponding 12-acetate derivative, which was an equipotent HIV-1 inhibitor, but with an activity that decreased considerably after plasma treatment.
合成了几种在12位带有醚取代基的新型佛波醇衍生物,并对其进行生物学评价以寻找抗HIV药物的新候选物。其中,12-O-(甲氧基甲基)佛波醇13-癸酸酯对MT-4细胞中HIV-1感染表现出强效抑制活性(EC50: 1.3 ng/mL)且细胞毒性相对较低(CC50: 8.3 μg/mL)。还发现该化合物与相应的12-乙酸酯衍生物相比在小鼠血浆中具有足够的稳定性,后者是一种等效的HIV-1抑制剂,但经血浆处理后活性大幅下降。